These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 9370951

  • 1. Expression of Fas ligand mRNA in germinal centres of the human tonsil.
    Kondo E, Yoshino T, Nishiuchi R, Sakuma I, Nishizaki K, Kayagaki N, Yagita H, Akagi T.
    J Pathol; 1997 Sep; 183(1):75-9. PubMed ID: 9370951
    [Abstract] [Full Text] [Related]

  • 2. Fas ligand expression in the germinal centre.
    Verbeke CS, Wenthe U, Zentgraf H.
    J Pathol; 1999 Oct; 189(2):155-60. PubMed ID: 10547568
    [Abstract] [Full Text] [Related]

  • 3. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
    Ungefroren H, Voss M, Jansen M, Roeder C, Henne-Bruns D, Kremer B, Kalthoff H.
    Cancer Res; 1998 Apr 15; 58(8):1741-9. PubMed ID: 9563493
    [Abstract] [Full Text] [Related]

  • 4. Fas-related apoptosis in gastric adenocarcinoma.
    Lim SC.
    Oncol Rep; 2003 Apr 15; 10(1):57-63. PubMed ID: 12469145
    [Abstract] [Full Text] [Related]

  • 5. Fas ligand expression is restricted to nonlymphoid thymic components in situ.
    French LE, Wilson A, Hahne M, Viard I, Tschopp J, MacDonald HR.
    J Immunol; 1997 Sep 01; 159(5):2196-202. PubMed ID: 9278307
    [Abstract] [Full Text] [Related]

  • 6. [The localization of FasL mRNA in liver tissues of chronic hepatitis B].
    Hu J, Zhang L, Zhao J.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Dec 01; 12(4):316-7. PubMed ID: 12526342
    [Abstract] [Full Text] [Related]

  • 7. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
    Bennett MW, O'Connell J, O'Sullivan GC, Brady C, Roche D, Collins JK, Shanahan F.
    J Immunol; 1998 Jun 01; 160(11):5669-75. PubMed ID: 9605174
    [Abstract] [Full Text] [Related]

  • 8. Limited expression of Fas and Fas ligand in fetal nucleated erythrocytes isolated from first trimester maternal blood.
    Sohda S, Samura O, Johnson KL, Falco VM, Elmes RS, Bianchi DW.
    Prenat Diagn; 2002 Dec 01; 22(13):1213-8. PubMed ID: 12478636
    [Abstract] [Full Text] [Related]

  • 9. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
    Viard-Leveugle I, Veyrenc S, French LE, Brambilla C, Brambilla E.
    J Pathol; 2003 Oct 01; 201(2):268-77. PubMed ID: 14517844
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Autocrine and paracrine apoptosis are mediated by differential regulation of Fas ligand activity in two distinct Jurkat T cell populations.
    Su X, Cheng J, Liu W, Liu C, Wang Z, Yang P, Zhou T, Mountz JD.
    J Immunol; 1998 Jun 01; 160(11):5288-93. PubMed ID: 9605126
    [Abstract] [Full Text] [Related]

  • 14. Fas/Fas ligand interactions are involved in ultraviolet-B-induced human lymphocyte apoptosis.
    Caricchio R, Reap EA, Cohen PL.
    J Immunol; 1998 Jul 01; 161(1):241-51. PubMed ID: 9647230
    [Abstract] [Full Text] [Related]

  • 15. Fas-Fas ligand-mediated apoptosis within aqueous during idiopathic acute anterior uveitis.
    Dick AD, Siepmann K, Dees C, Duncan L, Broderick C, Liversidge J, Forrester JV.
    Invest Ophthalmol Vis Sci; 1999 Sep 01; 40(10):2258-67. PubMed ID: 10476791
    [Abstract] [Full Text] [Related]

  • 16. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY, Yue P, Hong WK, Lotan R.
    Cancer Res; 2000 Nov 15; 60(22):6537-43. PubMed ID: 11103825
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Induction of Fas ligand (CD95L) by the toxic mistletoe lectins in human lymphocytes.
    Büssing A, Stein GM, Pfüller U, Schietzel M.
    Anticancer Res; 1999 Nov 15; 19(3A):1785-90. PubMed ID: 10470116
    [Abstract] [Full Text] [Related]

  • 19. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.
    Gastman BR, Atarshi Y, Reichert TE, Saito T, Balkir L, Rabinowich H, Whiteside TL.
    Cancer Res; 1999 Oct 15; 59(20):5356-64. PubMed ID: 10537320
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.